Department of Surgery, Technische Universität München, Ismaninger Strasse 22, Munich, Germany.
Dig Dis. 2010;28(2):344-9. doi: 10.1159/000319412. Epub 2010 Sep 1.
In patients suffering from chronic pancreatitis, pain as the predominant symptom remains a therapeutic challenge which often cannot be tackled conservatively. Since pancreatic duct obstruction - frequently within the pancreatic head - is an important etiological factor, treatment in these cases aims at decompressing the duct either endoscopically or surgically. Endoscopic drainage includes sphincterotomy, dilation of strictures, removal of stones, and insertion of a stent; it has a success rate of 30-100%. Surgical treatment may be accomplished by drainage or resection procedures. Drainage procedures (such as the longitudinal opening of the pancreatic duct followed by a pancreaticojejunostomy) can be performed with a low rate of postoperative complications (6-30%) and mortality (0-2%), and can achieve long-term pain relief in 65-85% of the cases. Furthermore, there are a variety of resection procedures such as pancreaticoduodenenectomy (Whipple procedure), pylorus-preserving pancreaticoduodenenectomy, different types of the duodenum-preserving pancreatic head resection (i.e. Beger, Frey, or Büchler procedures), segmentectomy, and V-shaped excision of the pancreatic duct. However, the surgical procedure of choice is controversially discussed. While it has been shown that parenchyma-preserving surgery is superior to more extensive resections, it remains unclear which of the modifications of the parenchyma-sparing procedures is suited best for which case. Recently, two randomized controlled trials have demonstrated that surgical treatment is superior to endotherapy in long-term pain reduction, physical health score results, and the number of reinterventions. Thus, in patients with chronic pancreatitis refractory to conservative medical treatment, surgery rather than endotherapy is the standard of care. Parenchyma-preserving resections should preferably be performed because they ensure lower morbidity and mortality, preserve endocrine function, and improve quality of life.
在患有慢性胰腺炎的患者中,疼痛作为主要症状仍然是一个治疗挑战,往往不能通过保守治疗解决。由于胰管阻塞 - 通常在胰头内 - 是一个重要的病因学因素,因此这些情况下的治疗旨在通过内镜或手术来减压胰管。内镜引流包括括约肌切开术、狭窄扩张、结石清除和支架插入;成功率为 30-100%。手术治疗可以通过引流或切除程序完成。引流程序(例如胰管的纵向开口,随后进行胰十二指肠吻合术)可以以较低的术后并发症发生率(6-30%)和死亡率(0-2%)进行,并且可以在 65-85%的病例中实现长期疼痛缓解。此外,还有各种切除程序,如胰十二指肠切除术(Whipple 手术)、保留幽门的胰十二指肠切除术、不同类型的保留十二指肠头的胰头切除术(即 Beger、Frey 或 Büchler 手术)、节段切除术和胰管 V 形切除术。然而,哪种手术程序是首选仍存在争议。虽然已经表明保留实质的手术优于更广泛的切除,但仍不清楚哪种保留实质的手术改良最适合哪种情况。最近,两项随机对照试验表明,手术治疗在长期减轻疼痛、身体健康评分结果和再次干预的数量方面优于内镜治疗。因此,对于对保守药物治疗有抗性的慢性胰腺炎患者,手术而不是内镜治疗是标准治疗方法。应优选进行保留实质的切除术,因为它们可以降低发病率和死亡率、保留内分泌功能并提高生活质量。